Inventor
IMBACH JEAN-LOUIS
FR39 patents
⚠️ This page may combine multiple inventors who share the name “IMBACH JEAN-LOUIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CENTRE NAT RECH SCIENT
8 patentsUS7138376B2Nov 21, 2006
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
CENTRE NAT RECH SCIENT81 citations98
US5770713AJun 23, 1998
Phosphorothioate triester oligonucleotides and method of preparation
CENTRE NAT RECH SCIENT216 citations97
US5639873AJun 17, 1997
Oligothionucleotides
CENTRE NAT RECH SCIENT1,193 citations95
US4476301AOct 9, 1984
Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon
CENTRE NAT RECH SCIENT1,209 citations95
US6555676B2Apr 29, 2003
Biologically active phosphotriester-type compounds
CENTRE NAT RECH SCIENT24 citations92
US5849905ADec 15, 1998
Biologically active phosphotriester-type nucleosides and methods for preparing same
CENTRE NAT RECH SCIENT26 citations92
US4816482AMar 28, 1989
Radioprotective agents having an amino-thioalkyl structure
CENTRE NAT RECH SCIENT11 citations71
US5001158AMar 19, 1991
Nitrosoureas compounds preparation thereof and utilization thereof in anticancerous
CENTRE NAT RECH SCIENT3 citations56
IDENIX PHARMACEUTICALS INC
6 patentsUS6875751B2Apr 5, 2005
3′-prodrugs of 2′-deoxy-β-L-nucleosides
IDENIX PHARMACEUTICALS INC131 citations99
US6569837B1May 27, 2003
β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC98 citations99
US6566344B1May 20, 2003
β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC122 citations99
US7585851B2Sep 8, 2009
3′-prodrugs of 2′-deoxy-β-L-nucleosides
IDENIX PHARMACEUTICALS INC69 citations98
US7304043B2Dec 4, 2007
β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC8 citations74
US7795238B2Sep 14, 2010
β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC3 citations63
UNIV EMORY
6 patentsUS6245749B1Jun 12, 2001
Nucleosides with anti-hepatitis B virus activity
UNIV EMORY55 citations96
US6525033B1Feb 25, 2003
Nucleosides with anti-hepatitis B virus activity
UNIV EMORY21 citations93
US6458773B1Oct 1, 2002
Nucleoside with anti-hepatitis B virus activity
UNIV EMORY42 citations93
US6407077B1Jun 18, 2002
β-L nucleosides for the treatment of HIV infection
UNIV EMORY32 citations93
US5990093ANov 23, 1999
Treating HBV with phospholipid prodrugs of β-L-2',3'-dideoxyadenosine 5'-monophosphate
UNIV EMORY36 citations93
US7468357B2Dec 23, 2008
Nucleosides with anti-hepatitis B virus activity
UNIV EMORY4 citations63
(unassigned)
4 patentsUS5627185AMay 6, 1997
Acyclovir derivatives as antiviral agents
58 citations96
US5955591ASep 21, 1999
Phosphotriester oligonucleotides, amidites and method of preparation
45 citations94
US5770725AJun 23, 1998
Phosphotriester type biologically active compounds
22 citations93
US6020482AFeb 1, 2000
Phosphotriester type biologically active compounds
9 citations74
ISIS PHARMACEUTICALS INC
3 patentsUS6124445ASep 26, 2000
Phosphotriester oligonucleotides, amidities and method of preparation
ISIS PHARMACEUTICALS INC239 citations98
US5952490ASep 14, 1999
Oligonucleotides having a conserved G4 core sequence
ISIS PHARMACEUTICALS INC69 citations94
US6399589B1Jun 4, 2002
Biologically active phosphotriester-type compounds
ISIS PHARMACEUTICALS INC3 citations62
NOVIRIO PHARMACEUTICALS LTD
2 patentsUAB RESEARCH FOUNDATION
2 patentsUS6896900B2May 24, 2005
β-L-2'-deoxy-nucleosides for the treatment of HIV infection
UAB RESEARCH FOUNDATION24 citations93
US7439351B2Oct 21, 2008
2′ or 3′ -deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents
UAB RESEARCH FOUNDATION0 citations36